Search clinical trials for: Genotropin (somatropin)

Total 336 results

OPKO Health, Inc.

Active, not recruiting

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Pediatric Growth Hormone Deficiency

Israel, United States, India, Korea, Republic of, Australia, Taiwan, Spain, Argentina, Belarus, Bulgaria, Canada, Colombia, Georgia, Greece, Mexico, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
Pfizer

Completed

Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"

Small for Gestational Age (SGA)
Pfizer

Completed

Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

Short Stature Born Small for Gestational Age (SGA)

Japan
Pfizer

Completed

Long Term Use of Somatropin in Patients Small for Gestational Age

Small for Gestational Age
University of Erlangen-Nürnberg Medical School

Completed

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin (ISS)

Idiopathic Short Stature

Germany
The University of Texas Medical Branch, Galveston

Completed

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

COVID-19 | Fatigue | Cognitive Impairment | Traumatic Brain Injury

United States
Joe Springer

Completed

Growth Hormone and Brain Functioning After Traumatic Brain Injury (GH)

Traumatic Brain Injury

United States
Massachusetts General Hospital

Completed

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Growth Hormone Deficiency

United States
Pfizer

Completed

Genotropin Treatment In Very Young Children Born Small For Gestational Age (EGN)

Infant, Small for Gestational Age

Czech Republic, Spain, Sweden, Netherlands, Belgium, France, Germany, Italy, Switzerland
Pfizer

Withdrawn

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.

Brain Injuries
OPKO Health, Inc.

Completed

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Pediatric Growth Hormone Deficiency

Greece, Hungary, Slovakia
Pfizer

Completed

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

Growth Hormone Deficiency

United States, United Kingdom, Bulgaria, Czechia, Slovakia
Erasmus Medical Center
Foundation for Prader-Willi Research; Prader-Willi Fonds

Not yet recruiting

Growth Hormone Study in Adults With Prader-Willi Syndrome (GAP)

Prader-Willi Syndrome

Netherlands
Northwell Health

Recruiting

Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

Growth | Growth Disorders | Growth Failure | Growth Hormone Treatment

United States
Nationwide Children's Hospital
Pfizer

Terminated

Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease

Crohn Disease | Arthritis, Juvenile Rheumatoid

United States
OPKO Health, Inc.

Completed

Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency

Growth Hormone Deficiency

Japan
The University of Texas Medical Branch, Galveston
The Moody Foundation

Completed

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

Traumatic Brain Injury | Growth Hormone Deficiency

United States
Baylor College of Medicine
United States Department of Defense

Recruiting

Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) (GWIT)

Gulf War Syndrome | Adult Growth Hormone Deficiency

United States
Rebecca Knickmeyer Santelli, PhD
Pfizer

Completed

Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome

Turner Syndrome

United States
Massachusetts General Hospital

Unknown

Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

Fetal Growth Retardation

United States
Ferring Pharmaceuticals

Completed

An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

Infertility

Denmark
The University of Texas Medical Branch, Galveston
Pfizer; United States Department of Defense

Completed

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

Burns | Growth Hormone Treatment

United States
Hanmi Pharmaceutical Company Limited

Completed

Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients (HM10560A)

Adult Growth Hormone Deficiency

Hungary
Ferring Pharmaceuticals

Completed

Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. (SHOview)

Ovarian Hyperstimulation Syndrome (OHSS)

France
LG Life Sciences

Completed

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Prader-Willi Syndrome

Korea, Republic of
Xiamen Amoytop Biotech Co., Ltd.
Peking Union Medical College Hospital

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Pegylated-Somatropin in Healthy Volunteers (Somatropin)

Healthy

China
Ferring Pharmaceuticals

Completed

Menopur Mixed Protocol (COMBINE)

Infertility

United States
Pfizer

Completed

Genotropin Study Assessing Use of Injection Pen

Growth Hormone Deficiency | Idiopathic Short Stature

United States
Ferring Pharmaceuticals

Completed

A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility

Infertility

Korea, Republic of
Zekai Tahir Burak Women's Health Research and Education...

Completed

hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF

Polycystic Ovary Syndrome

Turkey
Pfizer

Active, not recruiting

Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

Prader-Willi Syndrome

Japan
Ferring Pharmaceuticals

Completed

A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur® (AME)

Infertility

France
Ferring Pharmaceuticals

Completed

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population (MEGASET HR)

Infertility

United States
Pfizer

Completed

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Idiopathic Short Stature

United States
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Active, not recruiting

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Dwarfism

China
Pfizer

Completed

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Growth Hormone Deficiency

France
Novo Nordisk A/S

Completed

Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658

Noonan Syndrome | Genetic Disorder

Sweden
Novo Nordisk A/S

Completed

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

Noonan Syndrome | Genetic Disorder

Japan
LG Chem

Completed

6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

Korea, Republic of
Novo Nordisk A/S

Completed

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

Foetal Growth Problem | Small for Gestational Age

Japan
Novo Nordisk A/S

Completed

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Achondroplasia | Genetic Disorder

Japan
Novo Nordisk A/S

Completed

Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

Noonan Syndrome | Genetic Disorder

Sweden
Novo Nordisk A/S

Withdrawn

Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers

Healthy | Growth Disorder
Novo Nordisk A/S

Completed

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

Noonan Syndrome | Genetic Disorder

Japan
Novo Nordisk A/S

Completed

Safety and Efficacy of Long-term Somatropin Treatment in Adults (NordiWIN)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Germany
Pfizer

Completed

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

Growth Disorders
Ludwig-Maximilians - University of Munich
Pfizer

Completed

Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis | Still Disease, Juvenile-Onset

Germany
Novo Nordisk A/S

Completed

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

Small for Gestational Age | Growth Disorder

France
Novo Nordisk A/S

Completed

Observational Prospective Study on Patients Treated With Norditropin®

Chronic Kidney Disease | Turner Syndrome | Noonan Syndrome | Chronic Renal Insufficiency | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency | Genetic Disorder | Foetal Growth Problem | Small for Gestational Age

Israel, Saudi Arabia, Spain, Argentina, Russian Federation, Germany, Netherlands, Italy, Belgium, United Kingdom, Slovenia, Ireland, Sweden, Denmark, Hungary, Finland, Norway, France, Czechia, Lithuania, Luxembourg, Serbia, Switzerland
Novo Nordisk A/S

Completed

Growth Response in Girls With Turner Syndrome

Turner Syndrome | Genetic Disorder

France

Search clinical trials for: Genotropin (somatropin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations